Tang Capital Management LQDA Position
ExitedTang Capital Management exited their position in Liquidia Corporation (LQDA) in Q4 2025, after holding the stock for 8 quarters.
The position was first reported in Q1 2024 and has been tracked across 8 quarterly 13F filings.
1 other tracked fund also holds LQDA.
There is an upcoming Phase 3 readout for L606 in 1202 days (Jul 31, 2029), making the timing of Tang Capital's position particularly relevant.
Short interest stands at 17.2% of float with 5.9 days to cover, indicating significant bearish positioning against the stock.
About Liquidia Corporation
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
Full company profile →Short Interest
17.2%
5.9 days to cover
Tang Capital Management LQDA Position History
| Quarter | Action | Shares | Change | Value |
|---|---|---|---|---|
| Q4 2025 | Exited | 0 | -1,143,759 | $0 |
| Q3 2025 | Held | 1,143,759 | — | $26.0M |
| Q2 2025 | Decreased | 1,143,759 | -56,241 | $14.3M |
| Q1 2025 | Increased | 1,200,000 | +100,000 | $17.7M |
| Q4 2024 | Increased | 1,100,000 | +300,000 | $12.9M |
| Q3 2024 | Increased | 800,000 | +450,000 | $8.0M |
| Q2 2024 | Increased | 350,000 | +200,000 | $4.2M |
| Q1 2024 | New | 150,000 | +150,000 | $2.2M |
Frequently Asked Questions
Does Tang Capital Management own LQDA?
No. Tang Capital Management exited their position in Liquidia Corporation (LQDA) in Q4 2025. They previously held the stock for 8 quarters.
How many hedge funds own LQDA?
1 specialist biotech hedge fund currently holds LQDA, including Deerfield Management. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did Tang Capital Management first buy LQDA?
Tang Capital Management's position in LQDA was first reported in Q1 2024. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is Tang Capital Management's LQDA position increasing or decreasing?
Tang Capital Management completely exited their LQDA position in the most recent quarter.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
LQDACompany Page →
All fund holders, insider trades, catalysts, and cash runway
Tang Capital ManagementPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →